Firefly Neuroscience Inc. (AIFF)
Firefly Neuroscience Statistics
Share Statistics
Firefly Neuroscience has 11.62M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 256 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is -, so null% of the outstanding shares have been sold short.
| Short Interest | - |
| Short % of Shares Out | null% |
| Short % of Float | null% |
| Short Ratio (days to cover) | null |
Valuation Ratios
The PE ratio is -1.66 and the forward PE ratio is null. Firefly Neuroscience's PEG ratio is 0.
| PE Ratio | -1.66 |
| Forward PE | n/a |
| PS Ratio | 160.64 |
| Forward PS | null |
| PB Ratio | -46.26 |
| P/FCF Ratio | -2.64 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Firefly Neuroscience.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53, with a Debt / Equity ratio of -1.85.
| Current Ratio | 0.53 |
| Quick Ratio | 0.53 |
| Debt / Equity | -1.85 |
| Debt / EBITDA | -0.07 |
| Debt / FCF | -0.11 |
| Interest Coverage | -145.71 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $8.31K |
| Profits Per Employee | $-804.62K |
| Employee Count | 13 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2K |
| Effective Tax Rate | -0.02% |
Stock Price Statistics
The stock price has increased by -51.64% in the last 52 weeks. The beta is 2.97, so Firefly Neuroscience's price volatility has been higher than the market average.
| Beta | 2.97 |
| 52-Week Price Change | -51.64% |
| 50-Day Moving Average | 4.9 |
| 200-Day Moving Average | 4.23 |
| Relative Strength Index (RSI) | 40.85 |
| Average Volume (20 Days) | 6.54M |
Income Statement
In the last 12 months, Firefly Neuroscience had revenue of 108K and earned -10.46M in profits. Earnings per share was -1.6.
| Revenue | 108K |
| Gross Profit | 108K |
| Operating Income | -10.05M |
| Net Income | -10.46M |
| EBITDA | -10.32M |
| EBIT | -10.39M |
| Earnings Per Share (EPS) | -1.6 |
Balance Sheet
The company has 1.81M in cash and 694K in debt, giving a net cash position of 1.12M.
| Cash & Cash Equivalents | 1.81M |
| Total Debt | 694K |
| Net Cash | 1.12M |
| Retained Earnings | -87.08M |
| Total Assets | 4.6M |
| Working Capital | -2.35M |
Cash Flow
In the last 12 months, operating cash flow was -6.16M and capital expenditures -415K, giving a free cash flow of -6.57M.
| Operating Cash Flow | -6.16M |
| Capital Expenditures | -415K |
| Free Cash Flow | -6.57M |
| FCF Per Share | -1 |
Margins
Gross margin is 100%, with operating and profit margins of -9309.26% and -9685.19%.
| Gross Margin | 100% |
| Operating Margin | -9309.26% |
| Pretax Margin | -9683.33% |
| Profit Margin | -9685.19% |
| EBITDA Margin | -9557.41% |
| EBIT Margin | -9309.26% |
| FCF Margin | -6083.33% |
Dividends & Yields
AIFF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for AIFF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 18, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 18, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -28.12 |
| Piotroski F-Score | 2 |